AXCELIS TECHNOLOGIES INC (ACLS)

US0545402085 - Common Stock

111.45  +4.81 (+4.51%)

After market: 112.75 +1.3 (+1.17%)

Fundamental Rating

7

ACLS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ACLS is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, ACLS could be worth investigating further for growth and quality investing!.



8

1. Profitability

1.1 Basic Checks

In the past year ACLS was profitable.
In the past year ACLS had a positive cash flow from operations.
ACLS had positive earnings in each of the past 5 years.
Of the past 5 years ACLS 4 years had a positive operating cash flow.

1.2 Ratios

With an excellent Return On Assets value of 19.21%, ACLS belongs to the best of the industry, outperforming 93.40% of the companies in the same industry.
ACLS has a Return On Equity of 28.47%. This is amongst the best in the industry. ACLS outperforms 87.74% of its industry peers.
The Return On Invested Capital of ACLS (23.70%) is better than 95.28% of its industry peers.
ACLS had an Average Return On Invested Capital over the past 3 years of 22.37%. This is significantly above the industry average of 10.73%.
The last Return On Invested Capital (23.70%) for ACLS is above the 3 year average (22.37%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 19.21%
ROE 28.47%
ROIC 23.7%
ROA(3y)16.79%
ROA(5y)12.3%
ROE(3y)24.74%
ROE(5y)17.73%
ROIC(3y)22.37%
ROIC(5y)16.23%

1.3 Margins

ACLS has a Profit Margin of 21.78%. This is in the better half of the industry: ACLS outperforms 79.25% of its industry peers.
ACLS's Profit Margin has improved in the last couple of years.
ACLS has a Operating Margin of 23.51%. This is in the better half of the industry: ACLS outperforms 78.30% of its industry peers.
ACLS's Operating Margin has improved in the last couple of years.
The Gross Margin of ACLS (43.45%) is comparable to the rest of the industry.
ACLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.51%
PM (TTM) 21.78%
GM 43.45%
OM growth 3Y24.37%
OM growth 5Y11.64%
PM growth 3Y27.39%
PM growth 5Y16%
GM growth 3Y1.27%
GM growth 5Y1.38%

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ACLS is creating value.
ACLS has less shares outstanding than it did 1 year ago.
ACLS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACLS has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 7.66 indicates that ACLS is not in any danger for bankruptcy at the moment.
ACLS has a Altman-Z score of 7.66. This is in the better half of the industry: ACLS outperforms 73.58% of its industry peers.
The Debt to FCF ratio of ACLS is 0.33, which is an excellent value as it means it would take ACLS, only 0.33 years of fcf income to pay off all of its debts.
ACLS has a Debt to FCF ratio of 0.33. This is amongst the best in the industry. ACLS outperforms 82.08% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that ACLS is not too dependend on debt financing.
ACLS's Debt to Equity ratio of 0.05 is fine compared to the rest of the industry. ACLS outperforms 63.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.33
Altman-Z 7.66
ROIC/WACC1.95
WACC12.17%

2.3 Liquidity

ACLS has a Current Ratio of 3.79. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ACLS (3.79) is better than 63.21% of its industry peers.
ACLS has a Quick Ratio of 2.71. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.71, ACLS is in line with its industry, outperforming 58.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.79
Quick Ratio 2.71

8

3. Growth

3.1 Past

ACLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.08%, which is quite impressive.
Measured over the past years, ACLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.65% on average per year.
Looking at the last year, ACLS shows a very strong growth in Revenue. The Revenue has grown by 22.88%.
ACLS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.63% yearly.
EPS 1Y (TTM)36.08%
EPS 3Y76.12%
EPS 5Y40.65%
EPS growth Q2Q25.73%
Revenue 1Y (TTM)22.88%
Revenue growth 3Y33.56%
Revenue growth 5Y20.63%
Revenue growth Q2Q16.61%

3.2 Future

Based on estimates for the next years, ACLS will show a small growth in Earnings Per Share. The EPS will grow by 7.75% on average per year.
The Revenue is expected to grow by 10.27% on average over the next years. This is quite good.
EPS Next Y-6.41%
EPS Next 2Y7.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.09%
Revenue Next 2Y5.96%
Revenue Next 3Y10.27%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.00 indicates a correct valuation of ACLS.
ACLS's Price/Earnings ratio is rather cheap when compared to the industry. ACLS is cheaper than 88.68% of the companies in the same industry.
When comparing the Price/Earnings ratio of ACLS to the average of the S&P500 Index (28.28), we can say ACLS is valued slightly cheaper.
The Price/Forward Earnings ratio is 16.03, which indicates a correct valuation of ACLS.
ACLS's Price/Forward Earnings ratio is rather cheap when compared to the industry. ACLS is cheaper than 84.91% of the companies in the same industry.
ACLS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.88.
Industry RankSector Rank
PE 15
Fwd PE 16.03

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACLS is valued cheaply inside the industry as 91.51% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACLS indicates a rather cheap valuation: ACLS is cheaper than 83.02% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 26.67
EV/EBITDA 9.6

4.3 Compensation for Growth

ACLS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y7.75%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (5/3/2024, 7:00:00 PM)

After market: 112.75 +1.3 (+1.17%)

111.45

+4.81 (+4.51%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.63B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 15
Fwd PE 16.03
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.37
Profitability
Industry RankSector Rank
ROA 19.21%
ROE 28.47%
ROCE
ROIC
ROICexc
ROICexgc
OM 23.51%
PM (TTM) 21.78%
GM 43.45%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.79
Quick Ratio 2.71
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)36.08%
EPS 3Y76.12%
EPS 5Y
EPS growth Q2Q
EPS Next Y-6.41%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)22.88%
Revenue growth 3Y33.56%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y